Article Details
Retrieved on: 2023-01-09 20:55:43
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Reunion Neuroscience Inc. (NASDAQ: REUN) reported that it has completed the interim data analysis for its Phase 1 clinical trial with its lead ...
Article found on: www.greenmarketreport.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here